ATE304021T1 - Lektin-ähnliche domäne von thrombomodulin und therapeutische verwendung davon - Google Patents

Lektin-ähnliche domäne von thrombomodulin und therapeutische verwendung davon

Info

Publication number
ATE304021T1
ATE304021T1 AT02738105T AT02738105T ATE304021T1 AT E304021 T1 ATE304021 T1 AT E304021T1 AT 02738105 T AT02738105 T AT 02738105T AT 02738105 T AT02738105 T AT 02738105T AT E304021 T1 ATE304021 T1 AT E304021T1
Authority
AT
Austria
Prior art keywords
domain
lectin
thrombomodulin
meaning
inflammatory
Prior art date
Application number
AT02738105T
Other languages
English (en)
Inventor
Edward M Conway
Desire Collen
Original Assignee
Vlaams Interuniv Inst Biotech
D Collen Res Foundation Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE304021(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vlaams Interuniv Inst Biotech, D Collen Res Foundation Vzw filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of ATE304021T1 publication Critical patent/ATE304021T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT02738105T 2001-05-25 2002-05-24 Lektin-ähnliche domäne von thrombomodulin und therapeutische verwendung davon ATE304021T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201979 2001-05-25
PCT/EP2002/005727 WO2002096947A2 (en) 2001-05-25 2002-05-24 The lectin-like domain of thrombomodulin and its therapeutic use

Publications (1)

Publication Number Publication Date
ATE304021T1 true ATE304021T1 (de) 2005-09-15

Family

ID=8180374

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02738105T ATE304021T1 (de) 2001-05-25 2002-05-24 Lektin-ähnliche domäne von thrombomodulin und therapeutische verwendung davon

Country Status (7)

Country Link
US (1) US7341992B2 (de)
EP (1) EP1390407B1 (de)
AT (1) ATE304021T1 (de)
CA (1) CA2447629A1 (de)
DE (1) DE60206037T2 (de)
ES (1) ES2249586T3 (de)
WO (1) WO2002096947A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096947A2 (en) 2001-05-25 2002-12-05 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw The lectin-like domain of thrombomodulin and its therapeutic use
US20060148695A1 (en) * 2005-01-03 2006-07-06 National Cheng Kung University Novel angiogenic composition and use thereof
EP2014296A1 (de) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Neuartige Strategien zur Erhöhung der Reperfusion in einem verstopften Blutgefäß
AR067345A1 (es) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh Uso de trombomodulina para la preparacion de un medicamento trombolitico
US20120165244A1 (en) * 2008-10-30 2012-06-28 Hua-Lin Wu Methods for binding lewis y antigen
US20100113568A1 (en) * 2008-10-30 2010-05-06 Hua-Lin Wu Methods for binding lewis y antigen
US9775885B2 (en) * 2016-01-29 2017-10-03 Kaohsiung Medical Univeristy TMD1 protein for treating bone loss diseases
EP3811777B1 (de) 2019-10-27 2024-07-31 Shanghai RAAS Blood Products Co., Ltd. Genetisch modifizierte nicht-menschliche tiere
CN111296364B (zh) * 2019-10-27 2022-06-24 上海莱士血液制品股份有限公司 一种基因改造的小鼠动物模型基因改造方法及其应用
US11338019B2 (en) * 2020-05-24 2022-05-24 Yi-Hsun Huang Recombinant thrombomodulin domain 1 for use in treating eye diseases associated with pathological ocular angiogenesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
JP3189052B2 (ja) * 1990-06-27 2001-07-16 持田製薬株式会社 抗血液凝固活性を有するポリペプチド
EP0965597A4 (de) * 1996-12-27 2003-01-08 Mochida Pharm Co Ltd Zellmembran-wirksame medikamente
JP4256497B2 (ja) * 1998-08-06 2009-04-22 旭化成ファーマ株式会社 血管炎治療剤
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
WO2002096947A2 (en) 2001-05-25 2002-12-05 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw The lectin-like domain of thrombomodulin and its therapeutic use

Also Published As

Publication number Publication date
WO2002096947A2 (en) 2002-12-05
US20050014220A1 (en) 2005-01-20
WO2002096947A3 (en) 2003-09-04
EP1390407B1 (de) 2005-09-07
DE60206037T2 (de) 2006-07-13
US7341992B2 (en) 2008-03-11
CA2447629A1 (en) 2002-12-05
ES2249586T3 (es) 2006-04-01
DE60206037D1 (de) 2005-10-13
WO2002096947A8 (en) 2003-02-13
EP1390407A2 (de) 2004-02-25

Similar Documents

Publication Publication Date Title
Ezekowitz Role of the mannose-binding lectin in innate immunity
DE60332358D1 (de) Protease-resistente modifizierte interferon alpha polypeptide
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
Lo Re et al. CD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions
CY1119951T1 (el) Συνθεσεις για αυξηση δραστηριοτητας τελομερασης και αγωγη λοιμωξης hiv
MX2007007032A (es) Compuestos de aminopirimidina y metodos de uso.
ATE430193T1 (de) Rekombinante alpha-l-iduronidase und behandlung von durch diese hervorgerufene mangelerkrankungen
DE60037578D1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
BR0011103A (pt) Composição farmacêutica, e, métodos para prevenção ou tratamento de um distúrbio caracterizado por deposição amilóide em um sujeito mamìfero, para determinar o prognóstico de um paciente que está sendo submetido a tratamento de um distúrbio amilóide e para prevenção ou tratamento de uma doença caracterizada por um depósito amilóide em um paciente
DE60206037D1 (de) Lektin-ähnliche domäne von thrombomodulin und therapeutische verwendung davon
CY1116164T1 (el) Προδρομη 4-σουλφαταση ν-ακετυλογαλακτο σαμινης, μεθοδοι θεραπευτικης αγωγης που χρησιμοποιουν το εν λογω ενζυμο και μεθοδοι για παραγωγη και καθαρισμο του εν λογω ενζυμου
ATE506375T1 (de) Gegen das c5-komponent des komplementsystems gerichtete antikörper und deren verwendung
CY1107248T1 (el) Συντηγμενες πρωτεϊνες
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
NO20052272L (no) CCR1-antagonister for behandling av blant annet demylinerene inflamasjonssykdom
DE60209721D1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
GB0322645D0 (en) Use of antisecretory factor peptides
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
Ruf Is APC activation of endothelial cell PAR1 important in severe sepsis?: Yes
Laumonnier et al. Regulation and function of anaphylatoxins and their receptors in allergic asthma
Mannucci et al. Factor VIII products in haemophilia A: one size fits all?
TR200200278T2 (tr) Kalsilitik bileşimler
ATE435649T1 (de) 4-brom-5-(2-chlor-benzoylamino)-1h-pyrazol-3- carbonsäure(phenyl)amid-derivate und verwandte verbindungen als bradykinin b1 receptor antagonisten zur behandlung von entzündlichen erkrankungen
DE60323973D1 (de) Verwendung von glykosaminglykanen wie z.b. heparin zur behandlung von atemerkrankungen wie copd
DE50103012D1 (de) Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1390407

Country of ref document: EP